LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Sender:
Lactation Information and Discussion <[log in to unmask]>
Subject:
From:
"Pam Holland, IBCLC" <[log in to unmask]>
Date:
Wed, 3 Sep 1997 09:06:15 -0400
Reply-To:
Lactation Information and Discussion <[log in to unmask]>
Parts/Attachments:
text/plain (24 lines)
<< I think that we have to be careful about how high a horse we sit on...
 there are many meds that are not approved for the use that they are used
 for... if motillium comes to the states i suspect that it will not be as a
 galactogue but that is what most of us will ask for it to be used for... >>

Dear Patricia, I still believe that if a drug is not FDA approved for a
certain purpose because of the risks involved in using it, a patient
certainly has the right to that information as well.  Certainly, she could
make an informed decision after ALL of the facts are presented to her.  Of
course drugs are used for other purposes than what they were initially
manufactured for, but the fact of the matter is that Parlodel no longer has
FDA approval for use to suppress lactation because of SERIOUS side effects
(including stroke and death).  The doctors in my area are very quick to
inform a mom that she cannot use an antidepressant and many other drugs that
are deemed safe with supervision.  This morning already, I have had a mom
that delivered 2 weeks ago call and ask me if it was safe for her to resume
breastfeeding after receiving her immunization for Rubella postpartum.  Her
doctor told her she must pump and dump for 31 days!!!  31 days of not
breastfeeding her newborn.  I am sorry but I simply do not understand how
some drugs can receive the approval of so many health care professionals,
while others are  considered "dangerous".
                                           Pam Holland, IBCLC
                                             BF Coord., Savannah, WIC

ATOM RSS1 RSS2